BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 27336863)

  • 1. Predicting the risk for lymphoma development in Sjogren syndrome: An easy tool for clinical use.
    Fragkioudaki S; Mavragani CP; Moutsopoulos HM
    Medicine (Baltimore); 2016 Jun; 95(25):e3766. PubMed ID: 27336863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low miR200b-5p levels in minor salivary glands: a novel molecular marker predicting lymphoma development in patients with Sjögren's syndrome.
    Kapsogeorgou EK; Papageorgiou A; Protogerou AD; Voulgarelis M; Tzioufas AG
    Ann Rheum Dis; 2018 Aug; 77(8):1200-1207. PubMed ID: 29779010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular B-cell clonality assay in minor salivary glands as a useful tool for the lymphoma risk assessment in Sjögren's syndrome.
    Benyamine A; Poulet A; Belenotti P; Nihous H; Ene N; Jarrot PA; Swiader L; Mancini J; Beaufils N; Essaydi A; Gabert J; Weiller PJ; Kaplanski G
    Joint Bone Spine; 2024 May; 91(3):105686. PubMed ID: 38161050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predicting the outcome of Sjogren's syndrome-associated non-hodgkin's lymphoma patients.
    Papageorgiou A; Ziogas DC; Mavragani CP; Zintzaras E; Tzioufas AG; Moutsopoulos HM; Voulgarelis M
    PLoS One; 2015; 10(2):e0116189. PubMed ID: 25723713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum, but Not Saliva, CXCL13 Levels Associate With Infiltrating CXCL13+ Cells in the Minor Salivary Gland Lesions and Other Histologic Parameters in Patients With Sjögren's Syndrome.
    Chatzis L; Goules AV; Stergiou IE; Voulgarelis M; Tzioufas AG; Kapsogeorgou EK
    Front Immunol; 2021; 12():705079. PubMed ID: 34484201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ectopic Germinal Center-Like Structures in Minor Salivary Gland Biopsy Tissue Predict Lymphoma Occurrence in Patients With Primary Sjögren's Syndrome.
    Sène D; Ismael S; Forien M; Charlotte F; Kaci R; Cacoub P; Diallo A; Dieudé P; Lioté F
    Arthritis Rheumatol; 2018 Sep; 70(9):1481-1488. PubMed ID: 29669392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictive markers of lymphomagenesis in Sjögren's syndrome: From clinical data to molecular stratification.
    Kapsogeorgou EK; Voulgarelis M; Tzioufas AG
    J Autoimmun; 2019 Nov; 104():102316. PubMed ID: 31431317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A biomarker for lymphoma development in Sjogren's syndrome: Salivary gland focus score.
    Chatzis L; Goules AV; Pezoulas V; Baldini C; Gandolfo S; Skopouli FN; Exarchos TP; Kapsogeorgou EK; Donati V; Voulgari PV; Mavragani CP; Gorgoulis V; De Vita S; Fotiadis D; Voulgarelis M; Moutsopoulos HM; Tzioufas AG
    J Autoimmun; 2021 Jul; 121():102648. PubMed ID: 34029875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Potential Role for Early Biomarker Testing as Part of a Modern, Multidisciplinary Approach to Sjögren's Syndrome Diagnosis.
    Beckman KA; Luchs J; Milner MS; Ambrus JL
    Adv Ther; 2017 Apr; 34(4):799-812. PubMed ID: 28283891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymphoid organisation in labial salivary gland biopsies is a possible predictor for the development of malignant lymphoma in primary Sjögren's syndrome.
    Theander E; Vasaitis L; Baecklund E; Nordmark G; Warfvinge G; Liedholm R; Brokstad K; Jonsson R; Jonsson MV
    Ann Rheum Dis; 2011 Aug; 70(8):1363-8. PubMed ID: 21715359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hematologic manifestations and predictors of lymphoma development in primary Sjögren syndrome: clinical and pathophysiologic aspects.
    Baimpa E; Dahabreh IJ; Voulgarelis M; Moutsopoulos HM
    Medicine (Baltimore); 2009 Sep; 88(5):284-293. PubMed ID: 19745687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential risk of non-Hodgkin's lymphoma in Italian patients with primary Sjögren's syndrome.
    Valesini G; Priori R; Bavoillot D; Osborn J; Danieli MG; Del Papa N; Gerli R; Pietrogrande M; Sabbadini MG; Silvestris F; Valsecchi L
    J Rheumatol; 1997 Dec; 24(12):2376-80. PubMed ID: 9415645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical features distinguishing lymphoma development in primary Sjögren's Syndrome--a retrospective cohort study.
    Risselada AP; Kruize AA; Bijlsma JW
    Semin Arthritis Rheum; 2013 Oct; 43(2):171-7. PubMed ID: 23664530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinicopathological findings consistent with primary Sjögren's syndrome in a subset of patients diagnosed with chronic fatigue syndrome: preliminary observations.
    Sirois DA; Natelson B
    J Rheumatol; 2001 Jan; 28(1):126-31. PubMed ID: 11196514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-SSA/SSB-negative Sjögren's syndrome shows a lower prevalence of lymphoproliferative manifestations, and a lower risk of lymphoma evolution.
    Quartuccio L; Baldini C; Bartoloni E; Priori R; Carubbi F; Corazza L; Alunno A; Colafrancesco S; Luciano N; Giacomelli R; Gerli R; Valesini G; Bombardieri S; De Vita S
    Autoimmun Rev; 2015 Nov; 14(11):1019-22. PubMed ID: 26162302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Usefulness of antibodies and minor salivary gland biopsy in the study of sicca syndrome in daily clinical practice.
    Santiago ML; Seisdedos MR; Garcia Salinas RN; Catalán Pellet A; Villalón L; Secco A
    Reumatol Clin; 2015; 11(3):156-60. PubMed ID: 25579246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lower frequency of focal lip sialadenitis (focus score) in smoking patients. Can tobacco diminish the salivary gland involvement as judged by histological examination and anti-SSA/Ro and anti-SSB/La antibodies in Sjögren's syndrome?
    Manthorpe R; Benoni C; Jacobsson L; Kirtava Z; Larsson A; Liedholm R; Nyhagen C; Tabery H; Theander E
    Ann Rheum Dis; 2000 Jan; 59(1):54-60. PubMed ID: 10627428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sjögren's syndrome in patients with newly diagnosed untreated non-Hodgkin's lymphoma.
    Andonopoulos AP; Tiniakou M; Melachrinou M; Sfountouris H; Bounas A; Zervas C; Zoumbos NC
    Rev Rhum Engl Ed; 1997 May; 64(5):287-92. PubMed ID: 9190001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High incidence of lymphoid infiltration on labial salivary gland biopsy in non-Hodgkin's lymphomas: clinical implications.
    Morel P; Quiquandon I; Janin A; Dupriez B; Desablens B; Gosselin B; Bauters F
    Br J Haematol; 1993 Sep; 85(1):93-8. PubMed ID: 8251415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Sjögren's syndrome and non-Hodgkin's lymphoma: from pathophysiology to treatment].
    Le Guern V; Mouthon L
    Presse Med; 2011 Dec; 40(12 Pt 1):1113-9. PubMed ID: 21964038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.